JPY 927.0
(-0.54%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -12.89 Billion JPY | -300.25% |
2022 | -3.22 Billion JPY | 61.93% |
2021 | -8.46 Billion JPY | -150.04% |
2020 | 16.9 Billion JPY | 220.37% |
2019 | 5.27 Billion JPY | -65.85% |
2018 | 15.45 Billion JPY | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q1 | -3.17 Billion JPY | -82.67% |
2023 Q4 | -1.73 Billion JPY | 80.03% |
2023 FY | -12.89 Billion JPY | -300.25% |
2023 Q3 | -8.69 Billion JPY | -1272.1% |
2023 Q2 | 742 Million JPY | 123.19% |
2023 Q1 | -3.19 Billion JPY | 51.71% |
2022 Q3 | 2.2 Billion JPY | -73.4% |
2022 Q1 | -7.1 Billion JPY | 73.66% |
2022 Q4 | -6.62 Billion JPY | -400.0% |
2022 FY | -3.22 Billion JPY | 61.93% |
2022 Q2 | 8.3 Billion JPY | 216.83% |
2021 FY | -8.46 Billion JPY | -150.04% |
2021 Q1 | 10.38 Billion JPY | 215.24% |
2021 Q3 | 3.52 Billion JPY | -23.57% |
2021 Q2 | 4.6 Billion JPY | -55.63% |
2021 Q4 | -26.97 Billion JPY | -866.06% |
2020 FY | 16.9 Billion JPY | 220.37% |
2020 Q2 | 4.15 Billion JPY | 349.37% |
2020 Q1 | -1.66 Billion JPY | 0.0% |
2020 Q3 | 11.12 Billion JPY | 167.52% |
2020 Q4 | 3.29 Billion JPY | -70.38% |
2019 FY | 5.27 Billion JPY | -65.85% |
2018 FY | 15.45 Billion JPY | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
DVx Inc. | 172.91 Million JPY | 7555.773% |
Seikagaku Corporation | 2.18 Billion JPY | 689.753% |
Eiken Chemical Co., Ltd. | 2.63 Billion JPY | 589.446% |
Create Medic Co., Ltd. | 154.02 Million JPY | 8470.233% |
Techno Medica Co., Ltd. | 1.34 Billion JPY | 1056.288% |
Rion Co., Ltd. | 2.65 Billion JPY | 586.054% |
Nihon Kohden Corporation | 17.02 Billion JPY | 175.719% |
Fukuda Denshi Co., Ltd. | 18.69 Billion JPY | 168.967% |
Japan Lifeline Co., Ltd. | 7.51 Billion JPY | 271.55% |
Japan Medical Dynamic Marketing, INC. | 1.27 Billion JPY | 1113.775% |
3-D Matrix, Ltd. | -255.5 Million JPY | -4945.694% |
CYBERDYNE Inc. | -1.47 Billion JPY | -773.442% |